| Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) Is A Low Float Biopharma On Radar Monday
March 17th Dear Reader,
Drop what you're doing and consider Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD).
GLMD is a past champ. Alerted previously this past August after closing at $.3019, it surged in pre-market the next day all the way to a mind-blowing high of $.8516!
That's a blockbuster run in the form of an approx. 182% move!
Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases.
Their lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study.
They are also developing Amilo-5MER, a 5 amino acid synthetic peptide and recently initiated a first in human study.
Learn More Here. -----
(Nasdaq: GLMD) - 2 Immediate Points Of Interest
#1. GLMD is a low float profile.
With roughly 1.31Mn shares in its float, the chances for heightened volatility on a daily basis could be ever-present.
#2. GLMD has multiple oversold technical indicators.
Barchart is reporting conditions that may signal a reversal could be nearing for GLMD.
A 9-Day and 14-Day Relative Strength Index both below 29% at close on Friday, along with a 14-Day Raw Stochastic of 4.86% and a 14-Day Williams %R of 95.14%, this Nasdaq idea may be viewed as undervalued from current levels. -----
Coverage is initiated on Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD).
Consider getting it on your watchlist quickly.
Sincerely, FierceAnalyst | Jaks Swift Editorial Writer
(Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.)
FierceInvestor.com (“FierceInvestor” or “FI”) is owned by SWN Media LLC, a single member limited liability company. Data is provided from third-party sources and FierceInvestor is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile FI brings to your attention. Any emojis used do not have a specific defined meaning and may be used inconsistently. We do not provide personalized in.vest.ment advice, are not in.vest.ment advisors, and any profiles we mention are not suitable for all in.vest.ors.
SWN Media LLC has not been compensated for the March 16th and 17th, 2025's profile on (GLMD:US). Neither SWN Media LLC or its member own shares of (GLMD:US).
Please see important disclosure information here: https://www.fierceanalyst.net/disclosure/ | 
Tidak ada komentar:
Posting Komentar